PharmaCompany Inc focusses on shaping the future of pharmaceutical business by providing strategic insights and services to its global bio-pharma clients. We work with Fortune 500 as well as small to mid-size biopharma clients and enable strategic decision-making along the R&D and marketing continuum. Our approach relies on a solid understanding of the pharmaceutical market which is rooted in research, clinical, and market perspectives. Therapeutic Area Expertise: Neuroscience, Neuroinflammatory Disorders, Neurodegenerative Disorders, Neuroprotective Therapy, Oncology, Cardiovascular (Arterial and Venous Occlusive Diseases), Metabolic Diseases, Dermatology, Immunology, Macular Degeneration, Stem Cell Therapy, Gene Therapy, Infectious Diseases (Community and Hospital-Acquired Infections), and Rare/Orphan Diseases. Neuroscience Disease Area Expertise: Epilepsy, Stroke, TBI and Spinal Cord Injury, Multiple Sclerosis and Neuromyelitis Optica, Alzheimer's Disease, Huntigton's Disease, Parkinson's Disease, ALS, Spinal Muscular Atrophy, Myasthenia Gravis, Motor Neuron Disorders, Muscular Dystrophies, Neural Stem Cells, and Neuroregeneration. Cardiovascular Disease Area Expertise: Acute Coronary Syndrome, Arterial Thrombosis and PAOD, Deep Vein Thrombosis, and Surgical Procedures. Oncology Disease Area Expertise: Breast, Colorectal, Lung (NSCLC and SCLC), Prostate, Ovarian, Gastric, Hepatic, Glioblastoma, Leukemias, Lymphomas , Multiple Myeloma, and Cancer Vaccines.
